Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 3/20 | 0.60 |
| ▸ | HRH1 | P35367 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | AR | P10275 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5936690 | 0.88 | PDPK1 (0.55) | PIN1HRH1TP53KDM4EALDH1A1 | |
| SCHEMBL27799043 | 0.78 | KDM4E (0.61) | HRH1KDM4EALDH1A1LMNAHSD17B10 | |
| SCHEMBL28375287 | 0.76 | PIN1 (0.83) | PIN1TP53KDM4EALDH1A1LMNA | |
| SCHEMBL28372577 | 0.75 | PIN1 (1.00) | PIN1HRH1TP53LMNASMN1; SMN2 | |
| SCHEMBL17898057 | 0.75 | HRH1 (1.00) | PIN1HRH1TP53ALDH1A1TSHR | |
| SCHEMBL28375083 | 0.75 | PIN1 (1.00) | PIN1TP53LMNASMN1; SMN2MAPT | |
| SCHEMBL1122732 | 0.75 | KDM4E (0.62) | KDM4EALDH1A1SMN1; SMN2MAPTMAPK1 | |
| SCHEMBL1122737 | 0.74 | PKM (0.60) | PIN1TP53KDM4EALDH1A1TSHR | |
| SCHEMBL28375290 | 0.74 | PIN1 (0.83) | PIN1TP53KDM4EALDH1A1LMNA | |
| SCHEMBL5369562 | 0.74 | FAAH (0.53) | PIN1HRH1TP53ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | PPARD, PPARA, PPARG | PIN1 3142/4885HRH1 554/4885TP53 1778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.